| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | OSCR Oscar Health, Inc. | Quane Alessandrea C.51 | EVP, Chief Insurance Officer | Sell | 49,355 | $7.18 | $354,280.06 | -37.4% | -18.9% | -24.4% | |
| Feb 15, 2022 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 207 | $273.98 | $56,713.86 | -3.0% | -8.4% | -5.4% | |
| Feb 15, 2022 | LH Labcorp Holdings Inc. | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 207 | $273.98 | $56,713.86 | -3.8% | -8.4% | -5.4% | |
| Feb 14, 2022 | DVA Davita Inc. | Price Paula A63 | Director | Sell | 700 | $113.64 | $79,550.80 | -58.8% | -12.1% | -27.1% | |
| Feb 11, 2022 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 1,000 | $42.00 | $42,000.00 | -1.2% | -18.2% | -22.5% | |
| Feb 11, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 600 | $42.00 | $25,200.00 | - | -18.2% | -22.5% | |
| Feb 10, 2022 | CVS Cvs Health Corp | Ludwig Edward J60 | Director | Buy | 1,000 | $105.90 | $105,904.40 | +5.8% | -6.5% | -13.4% | |
| Feb 10, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $40.57 | $675,853.24 | -1.0% | -19.0% | -22.4% | |
| Feb 8, 2022 | COR Cencora, Inc. | Collis Steven H | Chairman, President &CEO | Sell | 24,263 | $141.22 | $3,426,420.86 | -10.6% | +11.0% | +12.4% | |
| Feb 7, 2022 | ELV Elevance Health, Inc. | Penczek Ronald W52 | CAO &Controller | Sell | 2,763 | $453.48 | $1,252,965.24 | -57.9% | +9.5% | +7.4% | |
| Feb 7, 2022 | OPCH Option Care Health, Inc. | Booker Harriet | Chief Operating Officer | Sell | 6,000 | $23.61 | $141,660.00 | -4.5% | +14.0% | +19.7% | |
| Feb 7, 2022 | MCK McKesson Corp | Faber Tracy | EVP &Chief Hr Officer | Sell | 2,034 | $265.23 | $539,471.72 | -100.0% | +21.0% | +35.4% | |
| Feb 7, 2022 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 204 | $277.38 | $56,585.52 | -3.0% | -12.1% | -9.2% | |
| Feb 7, 2022 | LH Labcorp Holdings Inc. | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 218 | $277.38 | $60,468.84 | -4.0% | -12.1% | -9.2% | |
| Feb 3, 2022 | CVS Cvs Health Corp | Brennan Troyen A | EVP And Chief Medical Officer | Sell | 47,937 | $110.00 | $5,273,070.00 | -25.7% | -7.0% | -19.8% | |
| Feb 3, 2022 | COR Cencora, Inc. | Campbell Elizabeth S | Executive Vice President | Sell | 14,034 | $137.89 | $1,935,148.26 | -64.0% | +14.1% | +15.1% | |
| Feb 3, 2022 | COR Cencora, Inc. | Krikorian Lazarus46 | SVP &Chief Accounting Officer | Sell | 11,653 | $138.14 | $1,609,745.42 | -37.9% | +14.1% | +15.1% | |
| Feb 3, 2022 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 161 | $271.81 | $43,761.41 | -2.5% | -8.8% | -9.5% | |
| Feb 3, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $38.46 | $640,742.80 | -1.0% | +8.1% | -4.1% | |
| Feb 3, 2022 | LH Labcorp Holdings Inc. | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 172 | $271.81 | $46,751.32 | -3.2% | -8.8% | -9.5% | |
| Feb 2, 2022 | MCK McKesson Corp | Emerson Kevin | SVP, Controller &CAO | Sell | 25 | $256.17 | $6,404.25 | -98.9% | +19.3% | +42.6% | |
| Feb 1, 2022 | CVS Cvs Health Corp | Lotvin Alan60 | EVP&President-pharmacyservices | Sell | 21,386 | $106.50 | $2,277,566.23 | -25.9% | -8.7% | -16.3% | |
| Feb 1, 2022 | COR Cencora, Inc. | Mauch Robert P.46 | Executive Vice President | Sell | 44,492 | $137.04 | $6,097,183.68 | -51.4% | +8.6% | +18.5% | |
| Jan 28, 2022 | PIII P3 Health Partners Inc. | Balkin Michael | 10% Owner | Buy | 15,000 | $4.83 | $72,450.00 | +0.2% | +32.1% | -72.1% | |
| Jan 28, 2022 | CVS Cvs Health Corp | Clark James David51 | SVP, Cont &Chief Acct Officer | Sell | 6,059 | $109.00 | $660,431.00 | -25.7% | -7.2% | -18.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.